ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

David Marin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.